LFMD — LifeMD Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual cashflow statement for LifeMD, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3.53	-60.5	-61.3	-45	-17.8
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	1.38	39.2	18.2	18.6	14.6
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	2.07	8.8	9.13	-0.661	5.49
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	0.251	-12.1	-33.1	-22.9	8.82
Capital Expenditures	0	-0.398	-3.38	-8.89	-8.58
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Software Development Costs
Other Investing Cash Flow Items	-0.1	-0.4	-0.022	-5.01	-0.149
Acquisition of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-0.1	-0.798	-3.4	-13.9	-8.73
Financing Cash Flow Items	-0.373	-0.172	-0.444	-0.288	-0.762
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.775	21	68.6	-0.528	29.1
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.927	8.07	32.1	-37.4	29.2